Effect of glibenclamide and glimepiride treatment on the development of myocardial infarction in rats

Acta Physiologica Hungarica

Volumn 87, Issue 2, 2000, Pages 173-184

  El Reyani, Nasruddin E ^a   Baczko I ^a   Lepran I ^a   Papp, J Gy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Glibenclamide; Glimepiride; Myocardial infarct size; Rat

Indexed keywords

ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; NITROBLUE TETRAZOLIUM; SULFONYLUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIABETES MELLITUS; DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; RAT; SCAR FORMATION; TREATMENT OUTCOME;

ANIMALS; CORONARY VESSELS; GLYBURIDE; HEART VENTRICLES; HYPOGLYCEMIC AGENTS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIGATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SULFONYLUREA COMPOUNDS; SURVIVAL ANALYSIS;

EID: 0034494511     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Anversa, P., Beghi, C., Kikkawa, Y., Olivetti, G.: Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am. J. Pathol. 118, 484-492 (1985).
2. Aversano, T., Ouyang, P., Silverman, H.: Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ. Res. 69, 618-622 (1991).
3. ATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats. Eur. J. Pharmacol. 324, 77-83 (1997).
4. Ballagi-Pordany, G., Koszeghy, A., Koltai, M. Z., Aranyi, Z., Pogátsa, G.: Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds. Diabetes Res. Clin. Pract. 8, 109-114 (1990).
5. Bijlstra, P. J., Lutterman, J. A., Russel, F. G. M., Thien, T., Smits, P.: Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans. Diabetologia 39, 1083-1090 (1996).
6. Bril, A., Laville, M. P., Gout, B.: Effects of glibenclamide on ventricular arrhythmias and cardiac function in ischaemia and reperfusion in isolated rat heart. Cardiovasc. Res. 26, 1069-1076 (1992).
7. Capasso, J. M., Li, P., Zhang, X., Anversa, P.: Heterogeneity of ventricular remodeling after acute myocardial infarction in rats. Am. J. Physiol. 262, H486-H495 (1992).
8. ATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. Cardiovasc. Res. 28, 881-887 (1994).
9. Daut, J., Maier-Rudolph, W., von Beckerath, N., Mehrke, G., Gunther, K., Goedel-Meinen, L.: Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247, 1341-1344 (1990).
10. El-Reyani, N. E., Bozdogan, O., Baczkó, I., Leprán, I., Papp, J. Gy.: Comparison of the efficacy of glibenclamide and glimepiride in reperfusion-induced arrhythmias in rats. Eur. J. Pharmacol. 365, 187-192 (1999).
11. + channel openers and 'natural' cardioprotection. Trends Pharmacol. Sci. 13, 269-272 (1992).
12. Fishbein, M. C., Maclean, D., Maroko, P. R.: Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am. J. Pathol. 90, 57-70 (1978).
13. Geisen, K.: Special pharmacology of the new sulfonylurea glimepiride. Arzn.-Forsch. 38, 1120-1130 (1988).
14. Geisen, K., Végh, A., Krause, E., Papp, J. Gy.: Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm. Metab. Res. 28, 496-507 (1996).
15. Grover, G. J.: Protective effects of ATP sensitive potassium channel openers in models of myocardial ischaemia. Cardiovasc. Res. 28, 778-782 (1994).
16. Grover, G. J., Sleph, P. G., Dzwonczyk, S.: Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine-A1-receptors. Circulation 86, 1310-1316 (1992).
17. + loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ. Res. 66, 478-485 (1990).
18. Kloner, R. A., Fishbein, M. C., Lew, H., Maroko, P. R., Braunwald, E.: Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 57, 56-63 (1978).
19. Komaru, T., Lamping, K. G., Eastham, C. L., Dellsperger, K. C.: Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ. Res. 69, 1146-1151 (1991).
20. Leprán, I., Baczkó, I., Varró, A., Papp, J. Gy.: ATP-Sensitive potassium channel modulators: Both pinacidil and glibenclamide produce antiarrhythmic activity during acute myocardial infarction in conscious rats. J. Pharmacol. Exp. Ther. 277, 1215-1220 (1996).
21. Leprán, I., Koltai, M., Siegmund, W., Szekeres, L.: Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J. Pharmacol. Meth. 9, 219-230 (1983).
22. Mannisi, J. A., Weisman, H. F., Bush, D. E., Dudeck, P., Healy, B.: Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat. J. Clin. Invest. 79, 1431-1439 (1987).
23. Miura, T., Goto, M., Miki, T., Sakamoto, J., Shimamoto, K., Iimura, O.: Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine-pentobarbital but not with pentobarbital alone. J. Cardiovasc. Pharmacol. 25, 531-538 (1995).
24. Munch-Ellingsen, J., Bugge, E., Ytrehus, K.: Blockade of the K-ATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Basic Res. Cardiol. 91, 382-388 (1996).
25. Nachlas, M. M., Shnitka, T. K.: Macroscopic identification of early myocardial infarct by alterations in dehydrogenase activity. Am. J. Pathol. 42, 379-405 (1963).
26. + channels in cardiac muscle. Nature 305, 147-149 (1983).
27. Ozaki, Y., Yatomi, Y., Kume, S.: Effects of oral hypoglycaemic agents on platelet functions. Biochem. Pharmacol. 44, 687-691 (1992).
28. Pogatsa, G., Koltai, M. Z., Jermendy, G., Simon, J., Aranyi, Z., Ballagi-Pordany, G.: The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients. Acta Med. Hung. 49, 39-51 (1992).
29. Pfeffer, J. M., Pfeffer, M. A., Braunwald, E.: Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57, 84-95 (1985).
30. Pfeffer, J. M., Pfeffer, M. A., Fletcher, P. J., Braunwald, E.: Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol. 260, H1406-H1414 (1991).
31. Porzio, S., Masseroli, M., Messori, A., Forloni, G., Olivetti, G., Jeremic, G., Riva, E., Luvara, G., Latini, R.: A simple, automatic method for morphometric analysis of the left ventricle in rats with myocardial infarction. J. Pharmacol. Toxicol. Methods 33, 221-229 (1995).
32. Rees, S. A., Curtis, M. J.: Pharmacological analysis in rat of the role of the ATP-sensitive potassium channel as a potential target for antifibrillatory intervention in acute myocardial ischaemia. J. Cardiovasc. Pharmacol. 26, 280-288 (1995).
33. Roberts, C. S., Maclean, D., Maroko, P., Kloner, R. A.: Early and late remodeling of the left ventricle after acute myocardial infarction. Am. J. Cardiol. 54, 407-410 (1984).
34. Rohmann, S., Weygandt, H., Schelling, P., Soei, L. K., Verdouw, P. D., Lues, I.: Involvement of ATP-sensitive potassium channels in preconditioning protection. Basic Res. Cardiol. 89, 563-576 (1994).
35. Schultz, J. E., Qian, Y. Z., Gross, G. J., Kukreja, R. C.: The ischemia-selective K-ATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29, 1055-1060 (1997).
36. Selye, H., Bajusz, E., Grasso, S., Mendell, P.: Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11, 398-407 (1960).
37. Thornton, J. D., Thornton, C. S., Sterling, D. L., Downey, J. M.: Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts. Circ. Res. 72, 44-49 (1993).
38. Tósaki, A., Szerdahelyi, P., Engelman, R. M., Das, D. K.: Potassium channel openers and blockers: Do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? J. Pharmacol. Exp. Ther. 267, 1355-1362 (1993).
39. Walker, M. J. A., Curtis, M. J., Hearse, D. J., Campbell, R. W. F., Janse, M. J., Yellon, D. M., Cobbe, S. M., Coker, S. J., Harness, J. B., Harron, D. W. G., Higgins, A. J., Julian, D. G., Lab, M. J., Manning, A. S., Northover, B. J., Parratt, J. R., Riemersma, R. A., Riva, E., Russell, D. C., Sheridan, D. J., Winslow, E., Woodward, B.: The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc. Res. 22, 447-455 (1988).
40. Wallenstein, S., Zucker, C. L., Fleiss, J. L.: Some statistical methods useful in circulation research. Circ. Res. 47, 1-9 (1980).
41. Wolleben, C. D., Sanquinetti, M. C., Siegl, P. K. S.: Influence of ATP-sensitive potassium modulators on ischemia-induced fibrillation isolated rat hearts. J. Mol. Cell. Cardiol. 21, 783-788 (1989).